BERDAZIMER SODIUM IS THE PROMISING DRUG FOR THE TREATMENT OF MOLLUSCUM CONTAGIOSUM
DOI:
https://doi.org/10.22159/ijpps.2024v16i10.51902Keywords:
Molluscum contagiosum, Berdazimer, Berdazimer sodium topical gel, Zelsuvmi, NITRICI™Abstract
Molluscum Contagiosum (MC) is an infectious dermatosis disease caused by Molluscum Contagiosum Virus (MCV). MC is treated with mechanical, chemical, immunomodulatory, and antiviral drugs. Predominantly, immunodeficiency HIV-positive patients expressing the resistance to MC lesions that effectively responded to available drug molecules, therefore, there is a need to develop an effective drug molecule for the treatment of MC infection. Berdazimer topical gel, 10.3% has been developed by Novan Inc. (Ligand Pharmaceuticals) under the brand name Zelsuvmi® for treating MC infection in adult and pediatric patients. Berdazimer topical gel, 10.3% is a Nitric Oxide (NO) releasing topical gel comprising novel NO-based technology platform NITRICI™, which stores gaseous NO species on large polymers.
Downloads
References
Bateman F. Molluscum contagiosum. In: Shelley WB, Crissey JT, eds. Classics in Dermatology. Springfield IL; Charles C Thomas, 1953, p20.
Brown ST, Nalley JF, Kraus SJ. MC Sex Transm Dis 1981 July-Sep;8(3):227-234.Doi: 10.1097/00007435-198107000-00012.
Juliusberg M., Zur Kenntnis des virus des Molluscum contagiosum. Dtsch Med Wochenschr 1905 31 (40): 1598-1599. Doi: 10.1055/s-0029-1188377
Wile and Kingery, J Cutan Dis., 1917 XXVII, p.431.
Bretz S. Molluscum Contagiosum. EmedicineJournal.2001 April; 2(4): 25
Pusey WA. Moluscum contagiosum In: The Principals and Practice of Dermatology, 4th ed. Appleton, 1924, pp 989-990.
Douglas JD, Tanner KN, Prine JR, Van Riper DC, Derwelis SK. MC in chimpanzees. J Am Vet Med Assoc 1967 Oct; 151: 901-904. Doi: 10.1136/vr.100721. Epub 2012 May 29.
Dangall BG, Witson GR: MC in a red kangaroo. Australas J Dermatol1974 December; 15: 115-120. Available from: https://doi.org/10.1111/j.1440-0960.1974.tb00545.x
IB Van Resburg, MG Collett, N Ronen, T Gerdes. MC in a horse. J S Afr Vet Assoc 1991 June; 62:72-74.
Available from: https://journals.co.za/doi/epdf/10.10520/AJA00382809_1443.
Janniger CK, Schwartz RA. MC in children. Cutis 1993 Oct; 52 (4): 194-196. Available from: https://pubmed.ncbi.nlm.nih.gov/8261802/
Oren B, Wende SO. An outbreak of MC in a kibbutz. Infection 1991 May; 19: 159-161.
Available from: https://sci-hub.se/https://link.springer.com/article/10.1007/BF01643239
Vander Straten M, Tyring SK. Mucocutaneous manifestations of viral diseases in children. Clin Dermatol 2002 Jan-Feb; 20: 67-73. Doi: https://doi.org/10.1016/S0738-081X(01)00233-4.
Sturt RJ, Muller HK, Francis GD. MC in villages of the West Septik district of New Guinea. Med J Aust 1971 Oct; 2(15): 751-754. Doi: 10.5694/j.1326-5377.1971.tb92526.x.
Becker TM, Blount JH, Douglas J, Judson FN. Trends in MC in the United States, 1966–1983. Sex Transm Dis. 1986 Apr-Jun; 13: 88-92. Available from: https://www.jstor.org/stable/44964078.
Silverberg NB, Sidbury R, Mancini AJ. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients. J Am Acad Dermatol 2000 Sep; 43: 503–507. Doi: 10.1067/mjd.2000.106370.
Epstein WL. Molluscum contagiosum. Semin Dermatol 1992 Sep; 11: 184-189. Available from: https://europepmc.org/article/med/1390033.
Cotton DWK, Cooper C, Barrett DF, Leppard BJ. Severe atypical MC infection in an immunocompromised host.Br J Dermatol. 1987 Jun; 116: 871-876.
Available from: https://doi.org/10.1111/j.1365-2133.1987.tb04908.x.
Wiederkehr M, Schwartz RA. Giant proliferative molluscum contagiosum. Acta Derm Venerol (Ljubljana) 2002; 11: 101–104.
Dangall BG, Wison GR. MC in a red kangaroo. Australas J Dermatol 1974 Dec; 15: 15: 115–120.Available from: https://doi.org/10.1111/j.1440-0960.1974.tb00545.x.
Epstein WL. Molluscum contagiosum. Semin Dermatol. 1992 Sep; 11: 184-189. Available from: https://pubmed.ncbi.nlm.nih.gov/1390033/
Sturt RJ, Muller HK, Francis GD. MC in villages of the West Septik district of New Guinea. Med J Aust 1971 Oct; 2 (15): 751-754. Doi: 10.5694/j.1326-5377.1971.tb92526.x.
Dangall BG, Wison GR. MC in a red kangaroo. Australas J Dermatol 1974 Dec; 15: 115–120.Available from: https://doi.org/10.1111/j.1440-0960.1974.tb00545.x.
Douglas JD, Tanner KN, Prine JR, Van Riper DC, Derwelis SK. MC in chimpanzees. J Am Vet Med Assoc 1967 Oct; 151(7): 901–904.Available from: https://pubmed.ncbi.nlm.nih.gov/6070316/.
Fife KH, Whitfeld M, Faust H, Goheen MP, Bryan J, Brown DR. Growth of MC virus in a human foreskin xenograft model. Virology 1996 Dec; 226(1): 95–101. Doi: 10.1006/viro.1996.0631.
Porter CD, Blake NW, Archard LC, Muhlemann MF, Rosedale N, Cream JJ. Molluscum contagiosumvirus types in genital and nongenital lesions. Br J Dermatol 1989 Jan; 120: 37-41
Doi: 10.1111/j.1365-2133.1989.tb07763.x.
Thompson CH. Immunoreactive proteins of MC virus types 1, 1v, and 2. J Infect Dis 1998; 178: 1230–1231. Available from: https://academic.oup.com/jid/article-abstract/178/4/1230/838012
Porter CD, Archard LC. Characterization by restriction mapping of three subtypes of MCvirus. J Med Virol 1992 Sep; 38: 1–6. Doi: 10.1002/jmv.1890380102.
Agromayor M, Ortiz P, Lopez-Estebaranz JL, et al. Molecular epidemiology of MC virus and analysis of the host – serum antibody response in Spanish HIV-negative patients. J Med Virol 2002 Feb; 66: 151–158. Doi: 10.1002/jmv.2124.
Cobbold RJ, Macdonald A. MC as a sexually transmitted disease. Practitioner. 1970Mar;204:416-9. Available from: https://pubmed.ncbi.nlm.nih.gov/5467224/
Schwartz JJ, Myskowski PL. MC in patients with human immunodeficiency virus infection. A review of twenty-seven patients. J Am Acad Dermatol. 1992;Oct;27:583-8. Doi: 10.1016/0190-9622(92)70226-6.
Ianhez M, Cestari SD, Enokihara MY, Seize MB. Dermoscopic patterns of molluscum contagiosum: a study of 211 lesions confirmed by histopathology. An Bras Dermatol 2011 Jan-Feb; 86 (1):74–79. Doi: 10.1590/s0365-05962011000100009.
Morales A, Puig S, Malvehy J, Zaballos P. Dermoscopy of molluscum contagiosum. Arch Dermatol. 2005 Dec;141(12):1644. doi:10.1001/archderm.141.12.164416365277
Zaballos P, Ara M, Puig S, Malvehy J. Dermoscopy of molluscum contagiosum: a useful tool for clinical diagnosis in adulthood. J EurAcad Dermatol Venereol. 2006 Apr;20(4):482–483. doi:10.1111/j.1468-3083.2006.01480.x16643165.
Lacarrubba F, Verzi AE, Ardigo M, Micali G. Handheld reflectance confocal microscopy for the diagnosis of molluscum contagiosum: histopathology and dermoscopy correlation. Australas J Dermatol. 2017 Aug ;58(3):e123–e125. doi:10.1111/ajd.1251127282954.
Scope A, Benvenuto-Andrade C, Gill M, Ardigo M, Gonzalez S, Marghoob AA. Reflectance confocal microscopy of molluscum contagiosum. Arch Dermatol. 2008;144(1):134. doi:10.1001/archderm.144.1.13418209192.
Choong KY, Roberts LJ. Molluscum contagiosum, swimming and bathing: a clinical analysis. Australas J Dermatol. 1999; 40:89–92. Doi: 10.1046/j.1440-0960.1999.00327.x.
Berbegal-DeGracia L, Betlloch-Mas I, DeLeon-Marrero F-J, Martinez-Miravete MT, Miralles-Botella J. Neonatal molluscum contagiosum: five new cases and a literature review. Australas J Dermatol. 2015 May;56 (2): e35–8. Doi: 10.1111/ajd.12127.
Forbat E, Al-Niaimi F, Ali FR. Molluscum contagiosum: review and update on management. Pediatr Dermatol. 2017 Sep;34 (5):504–15.Doi: 10.1111/pde.13228.
Janniger CK, Schwartz RA. MC in children. Cutis 1993 Oct;52: 194-196.Available from: https://pubmed.ncbi.nlm.nih.gov/8261802/
Thompson CH, Biggs IM, DeZwart-Steffe RT. Detection of MC virus DNA by in-situ hybridization. Pathology 1990 Oct;22:181-186. Doi: 10.3109/00313029009086657.
Tom W, Friedlander SF Poxvirus infections. In: Fitzpatrick TB, Freedberg IM, Eison AZ, Wolff K, Austenk F, Goldsmith LA, Katz SI (eds.). Fitzpatrick's Dermatology in General Medicine. 6th edition. New York, McGraw Hill-Company 2008; 34: 1081.
Sterling JC. Virus infections. In: Burns T, Breathnach S, Cox N, Griffith C (eds.). Rook's Textbook of Dermatology. 7th ed. London: Blackwell Publishing Company 2004; 25: 11-25.
ColoeJ and MorrellDS. Cantharidin use among pediatric dermatologists in the treatment of molluscum contagiosum. Pediatr. Dermatol. 2009 Jul-Aug; 26 (4): 405-408.
Doi: 10.1111/j.1525-1470.2008.00860.x
ColoeJ, BurkhartCN and Morrell DS Molluscum contagiosum: what’snew and true?
Pediatr. Ann. 2009 Jun; 38 (6): 321–325. Doi: 10.3928/00904481-20090513-01.
HarelA, Kutz AM, Hadj‐Rabia, S, Mashiah J.To treat MC or not‐curettage: an effective, well‐accepted treatment modality. Pediatr. Dermatol. 2016 Nov; 33 (6): 640–645.Doi: 10.1111/pde.12968.
Valentine CL, Diven D. Treatment modalities for molluscum contagiosum. Dermatol Ther. 2000 Dec; 13: 285-289. Available from: https://doi.org/10.1046/j.1529-8019.2000.00030.x
Neri I, Savoia F, Guareschi E, Medri M, Patrizi A. Purpura after application of EMLA cream in two children. Pediatr Dermatol. 2005 Nov-Dec; 22:566-8. Doi: 10.1111/j.1525-1470.2005.00142.x.
Cervigón I, Torres-Iglesias LM, Palomo Á. Purpura after application of a eutectic mixture of local anesthetic. ActasDermoSifiliogr. 2008 Jul-Aug; 99 (6):499-500. Available from: https://pubmed.ncbi.nlm.nih.gov/18558068/
Valentine CL, Diven D. Treatment modalities for molluscum contagiosum. Dermatol Ther. 2000;13: 285-9. Available from: https://doi.org/10.1046/j.1529-8019.2000.00030.x
Hughes, C.M., Damon, I.K., and Reynolds, M.G. (2013). Understanding U.S. healthcare providers’ practices and experiences with molluscum contagiosum. PLoS One 8: e76948.
Griffith RD, Yazdani Abyaneh MA, Falto‐Aizpurua, L, Nouri K. Pulsed dye laser therapy for molluscum contagiosum: a systematic review. J. Drugs Dermatol. 2014 Nov; 13 (11): 1349–1352.
Available from: https://pubmed.ncbi.nlm.nih.gov/25607701/
Ting PT, Dytoc MT. Therapy of external anogenital warts and molluscum contagiosum: a literature review. Dermatol Ther. 2004 Feb; 17: 68-101. Doi: 10.1111/j.1396-0296.2004.04009.x.
Bard S, Shiman MI, Bellman B, Connelly EA. Treatment of facial MC with trichloroacetic acid. Pediatr Dermatol. 2009 Jul-Aug;26:425-6. Doi: 10.1111/j.1525-1470.2009.00945.x.
Köse O, Ozmen I, Arca E. An open, comparative study of 10% potassium hydroxide solution versus salicylic and lactic acid combination in the treatment of MC in children. J Dermatolog Treat. 2013 Aug;24 (4):300-4. Doi: 10,3109/09546634,2011,649690.
Silverberg NB, Sidbury, R. and Mancini, AJ. Childhood molluscum contagiosum: experience with cantharidintherapy in 300 patients. J. Am. Acad. Dermatol. 2000 Sep; 43 (3): 503–507.
Doi: 10.1067/mjd.2000.106370.
Köse O, Ozmen I, Arca E. An open, comparative study of 10% potassium hydroxide solution versus salicylic and lactic acid combination in the treatment of MC in children.
J Dermatolog Treat. 2013 Aug ;24 (4): 300-4Doi: 10.3109/09546634,2011,649690
Semkova K, Palamaras I, Robles W. Hydrogen peroxide 1% cream under occlusion for treatment of MC in an 8-month-old infant: An effective and safe treatment option. Clin Exp Dermatol. 2014 Jun;39 (4):560-1. Doi: 10.1111/ced.12344.
Dohil M, Prendiville JS. Treatment of MC with oral cimetidine: clinical experience in 13 patients. Pharmacol Ther. 1996 Jul-Aug;13:310-2. Doi: 10.1111/j.1525-1470.1996.tb01247.x
Isaacs SN. Molluscum contagiosum. https://www.uptodate.com/contents/molluscum‐contagiosum?source=search_result&search=molluscum%20contagiosum&selectedTitle=1~52#H8725830.
HornTD, Johnson SM, Helm RMIntralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single‐blinded, randomized, and controlled trial. Arch. Dermatol. 2005 May; 141 (5): 589–594. Doi: 10.1001/archderm.141.5.589.
Erickson C, Driscoll M, Gaspari A. Efficacy of intravenous cidofovir in the treatment of giant MC in a patient with human immunodeficiency virus. Arch. Dermatol. 2011 June; 147 (6): 652-4.Doi: 10.1001/archdermatol.2011.20
Zabawski EJ Jr and Cockerell CJ Topical cidofovir for MC in children. Pediatr. Dermatol. 1999 Sep-Oct;16(5): 414. Available from: https://pubmed.ncbi.nlm.nih.gov/10627225/
De Clercq E. Cidofovir in the treatment of poxvirus infections. Trends Pharmacol Sci. 2002
Oct; 23 (10): 456-8.Doi: https://doi.org/10.1016/S0165-6147(02)02091-6.
Schwartz JJ. Myskowski PL: MC in patients with human immunodefificiency virus infection. J Am Acad Dermatol 1992 Oct; 27 (4): 583-8. Doi: 10.1016/0190-9622(92)70226-6.
Meadows KP, Tyring SK, Pavia AT, Ralis TM. Resolution of recalcitrant MC lesions in human immunodeficiency virus-infected patients treated with cidofovir. Arch Dermatol 1997: 133: 987–990. Available from: https://pubmed.ncbi.nlm.nih.gov/9267245/
Buckley R, Smith K. Topical imiquimod therapy for chronic giant MC in a patient with advanced human immunodeficiency virus 1 disease. Arch Dermatol 1999 Oct; 135 (10): 1167–1169. Doi: 10.1001/archderm.135.10.1167.
Hrabie JA, Keefer LK.Chemistry of the Nitric Oxide-releasing diazeniumdiolate (“nitrosohydroxylamine”) functional group and its oxygen-substituted derivatives. Chem. Rev. 2002 Apr, 102 (4), 1135–1154. Doi: 10.1021/cr000028t.
Novan Inc. Our Science: NITRICILTM. 2024. https://novan.com/our-science/. Accessed 31 Jan 2024.
LNHC Inc. ZELSUVMI™ (berdazimer topical gel, 10.3%): US prescribing information. 2024. Available from: https://zelsuvmi.com/Accessed Jan 9, 2024.
Ligand Pharmaceuticals Inc. Ligand acquires assets of Novan, Inc. for $12.2 million [media release]. 27 Sep 2023. Available from: https://investor.ligand.com/.
Ligand Pharmaceuticals Inc. Ligand acquires assets of Novan, Inc. for $12.2 million [media release]. 27 Sep 2023. Available from: https://investor.ligand.com/.
Ligand Pharmaceuticals Inc. U.S. Food and Drug Administration approves ZELSUVMI™ as a first-in-class medication for the treatment of MC [media release]. 5 Jan 2024. Available from: https://investor.ligand.com/.
RiccioDA, SchoenfischMH. Nitric Oxide release: Part I. Macromolecular scaffolds. Chem. Soc. Rev. 2012 May;41, 3731–3741. Doi: 10.1039/c2cs15272j.
Becker TM, Blount JH, Douglas J, Judson FN,Trends in MC in the United States, 1966-1983, Sex Transm Dis. 1986 Apr-Jun, 13(2):88-92. Doi: 10.1097/00007435-198604000-00007.
BrainKR, Walters KA, James VJ, Dressler WE, Howes D, Kelling CK, Moloney SJ, Gettings SD. Percutaneous penetration of dimethylnitrosamine through human skin in vitro: application from cosmetic vehicles, Food Chem.Toxicol. 1995 Apr; 33(4):315-322. Doi: doi:10.1016/0278-6915(94)00146-f.
DohilMA, Lin P, Lee J, Lucky AW and Eichenfield LF. The epidemiology of MC in children, J Am Acad Dermatol.2006 Jan; 54(1):47-54.
Doi: 10.1016/j.jaad.2005.08.035.
Hebert AA, Bhatia Nand Del Rosso JQ, Molluscum Contagiosum: Epidemiology,
Considerations, Treatment Options, and Therapeutic Gaps, J Clin Aesthet Dermatol. 2023 Aug; 16(8 Suppl 1): S4-S11. Available from: https://pubmed.ncbi.nlm.nih.gov/37636018/
Isaacs SN, MSE Hirsch, and AOE Ofori, 2023, UpToDate: Molluscum Contagiosum, Wolters
Kluwer Health, accessed June, 2023.
Konya J and CH. Thompson MC virus: antibody responses in persons with clinical lesions and seroepidemiology in a representative Australian population, J Infect Dis. 1999 Mar;179(3):701-704. Doi: 10.1086/314620.
Published
How to Cite
Issue
Section
Copyright (c) 2024 VIKRANT DANDEKAR, AMRIT KARMARKAR
This work is licensed under a Creative Commons Attribution 4.0 International License.
